Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo.

Hattori Y; Kubo T; Nagano S; Miyama T; Taniguchi Y; Iba Y; Ohshima N; Kanehara R; Kawase T; Takahashi M; Kawamoto H; Mihara K.

Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo.

Hattori Y, Kubo T, Nagano S, Miyama T, Taniguchi Y, Iba Y, Ohshima N, Kanehara R, Kawase T, Takahashi M, Kawamoto H, Mihara K.

Research output: Contribution to conference › Presentation

Original language	Japanese
State	Published - 2023
Event	65th ASH Annual Meeting and Exposition - Duration: 2023/01/01 → …

Conference

Conference	65th ASH Annual Meeting and Exposition
Period	2023/01/01 → …

Cite this

@conference{62f274adf3c849068ac6c21eb8a0ed28,

title = "Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo.",

author = "Hattori Y and Kubo T and Nagano S and Miyama T and Taniguchi Y and Iba Y and Ohshima N and Kanehara R and Kawase T and Takahashi M and Kawamoto H and Mihara K.",

year = "2023",

language = "日本",

note = "65th ASH Annual Meeting and Exposition ; Conference date: 01-01-2023",

}

TY - CONF

T1 - Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo.

AU - Y, Hattori

AU - T, Kubo

AU - S, Nagano

AU - T, Miyama

AU - Y, Taniguchi

AU - Y, Iba

AU - N, Ohshima

AU - R, Kanehara

AU - T, Kawase

AU - M, Takahashi

AU - H, Kawamoto

AU - K., Mihara

PY - 2023

Y1 - 2023

M3 - 学会発表

T2 - 65th ASH Annual Meeting and Exposition

Y2 - 1 January 2023

ER -